| Literature DB >> 36003697 |
John R Doty1, Michael Nguyen2, Richard J Snyder2, Ulysse G McCann1, Donald B Doty1.
Abstract
Background: The Core Curriculum Review Course in Cardiovascular and Thoracic Surgery is a 4-day educational program consisting of 77 didactic lectures that provide a comprehensive review of the material required for surgeons preparing for the American Board of Thoracic Surgery competency written examination. The lectures are supplemented with a written syllabus and interactive audience participation system. We sought to determine whether participation in this course could improve participants' performance on a cardiothoracic subject-based test.Entities:
Keywords: ABTS, American Board of Thoracic Surgery; education; residency; training
Year: 2021 PMID: 36003697 PMCID: PMC9390413 DOI: 10.1016/j.xjon.2021.07.003
Source DB: PubMed Journal: JTCVS Open ISSN: 2666-2736
Descriptive statistics for item responses in the 29 participants who completed both the pretest and posttest
| Variable | Number correct | Number incorrect | % correct | % incorrect | ||||
|---|---|---|---|---|---|---|---|---|
| Pretest | Posttest | Pretest | Posttest | Pretest | Posttest | Pretest | Posttest | |
| Minimum | 14 | 30 | 1 | 7 | 18 | 39 | 3 | 10 |
| Maximum | 75 | 69 | 55 | 47 | 97 | 90 | 82 | 61 |
| Average | 36 | 48 | 39 | 29 | 47 | 62 | 53 | 38 |
| Median | 36 | 47 | 41 | 30 | 47 | 61 | 53 | 39 |
| SD | 9.97 | 10.02 | 9.52 | 10.08 | 13 | 13 | 13 | 13 |
Figure 1Q-Q plot for pretest. The presence of nonnormal data and outliers in the dataset supports the use of a nonparametric test to assess differences between the pretest and posttest data. PREPER, Pretest performance.
Figure 2Q-Q plot for posttest. There are no outliers in this dataset, but there are nonnormal data, supporting the use of a nonparametric test to assess the differences between the pretest and posttest data. POSTPER, Posttest performance.
Figure 3Comparison of pretest and posttest scores by subject category. All categories demonstrate improvement in posttest scores, with the most marked improvements seen in the cardiovascular disease and esophageal disease categories.
Figure 4Methods, results, and implications of the study. Methods include administration of the pretest, attendance at the review course, administration of the posttest, and score analysis. Key results are an overall 14% improvement in mean score, a statistically significant change. Implications are that attendance at the review course increases the overall fund of knowledge, improves standardized test scores, and can help identify areas of focus for residency training programs.
| Q | Topic | N | FFEOOR | PRENOOR | PPETOTAL | FFE% | POSTOOR | POSTINOOR | POSTTOTAL | POST% | DFF |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Esophageal diagnostic procedures | 94 | 25 | 38 | 63 | 40 | 28.00 | 3.00 | 31.00 | 90 | 51 |
| 2 | Pulmonary diagnostic testing | 94 | 33 | 30 | 63 | 52 | 20.00 | 11.00 | 31.00 | 65 | 12 |
| 3 | Thoracic trauma | 93 | 5 | 57 | 62 | 8 | 14.00 | 17.00 | 31.00 | 45 | 37 |
| 4 | Bullous emphysema and pneumothorax | 94 | 34 | 29 | 63 | 54 | 21.00 | 10.00 | 31.00 | 68 | 14 |
| 5 | Pulmonary infections | 93 | 28 | 34 | 62 | 46 | 14.00 | 17.00 | 31.00 | 45 | 0 |
| 6 | Pulmonary fungus, tuberculosis | 93 | 21 | 41 | 62 | 34 | 10.00 | 21.00 | 31.00 | 32 | −2 |
| 7 | Mediastinal tumors | 93 | 8 | 54 | 62 | 13 | 14.00 | 17.00 | 31.00 | 45 | 32 |
| 8 | Pulmonary anomies | 93 | 31 | 31 | 62 | 50 | 24.00 | 7.00 | 31.00 | 77 | 27 |
| 9 | Lung cancer–diagnosis | 93 | 34 | 28 | 62 | 55 | 16.00 | 15.00 | 31.00 | 52 | −3 |
| 10 | Lung cancer–staging | 93 | 31 | 31 | 62 | 50 | 14.00 | 17.00 | 31.00 | 45 | −5 |
| 11 | Lung cancer–surgery | 93 | 15 | 47 | 62 | 24 | 23.00 | 8.00 | 31.00 | 74 | 50 |
| 12 | Lung cancer–metastatic disease and adjuvant therapy | 93 | 34 | 28 | 62 | 55 | 16.00 | 15.00 | 31.00 | 52 | −3 |
| 13 | Benign lung tumors | 93 | 46 | 16 | 62 | 74 | 29.00 | 2.00 | 31.00 | 94 | 19 |
| 14 | Thoracic outlet syndrome | 93 | 31 | 31 | 62 | 50 | 25.00 | 6.00 | 31.00 | 81 | 31 |
| 15 | SVC syndrome and pulmonary embolism | 93 | 17 | 45 | 62 | 27 | 12.00 | 19.00 | 31.00 | 39 | 11 |
| 16 | Chest wall congenital deformities and tumors | 93 | 23 | 39 | 62 | 37 | 10.00 | 21.00 | 31.00 | 32 | −6 |
| 17 | The diaphragm | 93 | 20 | 42 | 62 | 32 | 17.00 | 14.00 | 31.00 | 55 | 23 |
| 18 | The pleura | 93 | 18 | 44 | 62 | 29 | 22.00 | 9.00 | 31.00 | 71 | 42 |
| 19 | The trachea | 93 | 48 | 14 | 62 | 77 | 18.00 | 13.00 | 31.00 | 58 | −19 |
| 20 | Esophageal congenital disorders, burns/structure | 93 | 59 | 3 | 62 | 96 | 31.00 | 0.00 | 31.00 | 100 | 5 |
| 21 | Esophageal motility disorders | 93 | 12 | 50 | 62 | 19 | 24.00 | 7.00 | 31.00 | 77 | 58 |
| 22 | Gastroesophageal reflux disease and benign esophageal tumors | 93 | 10 | 52 | 62 | 16 | 11.00 | 20.00 | 31.00 | 35 | 19 |
| 23 | Esophageal cancer | 92 | 21 | 40 | 61 | 34 | 21.00 | 10.00 | 31.00 | 68 | 33 |
| 24 | Cardiac anatomy | 92 | 33 | 28 | 61 | 54 | 25.00 | 6.00 | 31.00 | 81 | 27 |
| 25 | CV physiology | 92 | 45 | 16 | 61 | 74 | 28.00 | 3.00 | 31.00 | 90 | 17 |
| 26 | CV pharmacology/coagulation | 92 | 48 | 13 | 61 | 79 | 27.00 | 4.00 | 31.00 | 87 | 8 |
| 27 | Critical care physiology | 92 | 21 | 40 | 61 | 34 | 17.00 | 14.00 | 31.00 | 55 | 20 |
| 28 | Acute heart failure | 92 | 45 | 16 | 61 | 74 | 23.00 | 8.00 | 31.00 | 74 | 0 |
| 29 | Cardiopulmonary bypass/myocardial protection | 92 | 25 | 36 | 61 | 41 | 22.00 | 9.00 | 31.00 | 71 | 30 |
| 30 | Coronary artery disease | 92 | 13 | 48 | 61 | 21 | 28.00 | 3.00 | 31.00 | 90 | 69 |
| 31 | Myocardial infarction | 92 | 22 | 39 | 61 | 36 | 17.00 | 14.00 | 31.00 | 55 | 19 |
| 32 | Myocardial revascularization | 92 | 40 | 21 | 61 | 66 | 21.00 | 10.00 | 31.00 | 68 | 2 |
| 33 | Postinfarction ventricular aneurysm and VSD | 92 | 29 | 32 | 61 | 48 | 25.00 | 6.00 | 31.00 | 81 | 33 |
| 34 | Ischemic mitral disease | 92 | 49 | 12 | 61 | 80 | 30.00 | 1.00 | 31.00 | 97 | 16 |
| 35 | Combined coronary/carotid/valvular disease | 92 | 6 | 56 | 61 | 10 | 9.00 | 22.00 | 31.00 | 29 | 19 |
| 36 | Aortic valve disease | 92 | 24 | 37 | 61 | 39 | 18.00 | 13.00 | 31.00 | 58 | 19 |
| 37 | Mitral valve disease | 92 | 8 | 53 | 61 | 13 | 12.00 | 19.00 | 31.00 | 39 | 26 |
| 38 | Tricuspid and multiple valve disease | 92 | 47 | 14 | 61 | 77 | 11.00 | 20.00 | 31.00 | 35 | −42 |
| 39 | Prosthetic valve selection | 92 | 29 | 32 | 61 | 48 | 21.00 | 10.00 | 31.00 | 68 | 20 |
| 40 | Endocarditis | 91 | 12 | 48 | 60 | 20 | 11.00 | 20.00 | 31.00 | 35 | 15 |
| 41 | Clinical trials in coronary artery disease | 91 | 8 | 52 | 60 | 13 | 29.00 | 2.00 | 31.00 | 94 | 80 |
| 42 | Thoracic radiography | 91 | 45 | 15 | 60 | 75 | 27.00 | 4.00 | 31.00 | 87 | 12 |
| 43 | Anesthesia and echocardiography | 91 | 15 | 45 | 60 | 25 | 13.00 | 18.00 | 31.00 | 42 | 17 |
| 44 | Cardiac tumors | 91 | 30 | 30 | 60 | 72 | 24.00 | 7.00 | 31.00 | 77 | 6 |
| 45 | Hypertrophic cardiomyopathy | 91 | 30 | 30 | 60 | 50 | 22.00 | 9.00 | 31.00 | 71 | 21 |
| 46 | The pericardium | 91 | 37 | 23 | 60 | 62 | 8.00 | 23.00 | 31.00 | 26 | −36 |
| 47 | Cardiac transplantation | 91 | 4 | 56 | 60 | 7 | 4.00 | 27.00 | 31.00 | 13 | 6 |
| 48 | Lung and heart-lung transplantation | 91 | 27 | 33 | 60 | 46 | 20.00 | 11.00 | 31.00 | 66 | 20 |
| 49 | Transplant immunology | 91 | 51 | 9 | 60 | 85 | 28.00 | 3.00 | 31.00 | 90 | 5 |
| 50 | Assisted circulation | 91 | 9 | 51 | 60 | 15 | 10.00 | 21.00 | 31.00 | 32 | 17 |
| 51 | Surgical treatment of heart failure | 91 | 35 | 25 | 60 | 58 | 3.00 | 28.00 | 31.00 | 10 | −49 |
| 52 | Cardiac arrhythmias | 91 | 28 | 32 | 60 | 47 | 29.00 | 2.00 | 31.00 | 94 | 47 |
| 53 | Aortic aneurysm | 91 | 15 | 45 | 60 | 25 | 13.00 | 18.00 | 31.00 | 42 | 17 |
| 54 | Aortic dissection | 91 | 37 | 23 | 60 | 62 | 26.00 | 5.00 | 31.00 | 84 | 22 |
| 55 | Complications and less invasive operations | 91 | 45 | 15 | 60 | 75 | 26.00 | 5.00 | 31.00 | 84 | 9 |
| 56 | Developmental anatomy | 91 | 3 | 57 | 60 | 5 | 6.00 | 25.00 | 31.00 | 19 | 14 |
| 57 | Palliative operations | 91 | 25 | 35 | 60 | 42 | 16.00 | 15.00 | 31.00 | 52 | 10 |
| 58 | Patent ductus arteriosus and aortopulmonary window | 91 | 20 | 40 | 60 | 33 | 11.00 | 20.00 | 31.00 | 35 | 2 |
| 59 | Coarctation of the aorta–interrupted aortic arch | 91 | 26 | 34 | 60 | 43 | 26.00 | 5.00 | 31.00 | 84 | 41 |
| 60 | Atrial septal defect and partial anomalous venous connection | 91 | 7 | 53 | 60 | 12 | 9.00 | 22.00 | 31.00 | 29 | 17 |
| 61 | Ventricular septal defect | 91 | 34 | 26 | 60 | 57 | 18.00 | 13.00 | 31.00 | 58 | 1 |
| 62 | Atrioventricular septal defect | 91 | 5 | 55 | 60 | 8 | 22.00 | 9.00 | 31.00 | 71 | 63 |
| 63 | Tetralogy of Fallot | 91 | 30 | 30 | 60 | 50 | 10.00 | 21.00 | 31.00 | 32 | −18 |
| 64 | Coronary anomalies | 91 | 15 | 45 | 60 | 25 | 14.00 | 17.00 | 31.00 | 40 | 20 |
| 65 | Truncus arteriosus | 91 | 37 | 23 | 60 | 62 | 27.00 | 4.00 | 31.00 | 87 | 25 |
| 66 | Pulmonary stenosis– pulmonary atresia | 90 | 40 | 19 | 59 | 68 | 29.00 | 2.00 | 31.00 | 94 | 26 |
| 67 | Vascular rings and sling | 90 | 22 | 37 | 59 | 37 | 9.00 | 22.00 | 31.00 | 29 | −8 |
| 68 | Congenital aortic stenosis | 90 | 26 | 33 | 59 | 44 | 21.00 | 10.00 | 31.00 | 68 | 24 |
| 69 | Sinus of Valsava aneurysm/fistula | 90 | 47 | 12 | 59 | 80 | 28.00 | 3.00 | 31.00 | 90 | 11 |
| 70 | Ebstein anomaly | 90 | 20 | 39 | 59 | 34 | 15.00 | 16.00 | 31.00 | 48 | 14 |
| 71 | Single ventricle anomalies | 90 | 40 | 19 | 59 | 68 | 28.00 | 3.00 | 31.00 | 90 | 23 |
| 72 | Hypoplastic left heart syndrome | 90 | 44 | 15 | 59 | 75 | 2.00 | 29.00 | 31.00 | 6 | −68 |
| 73 | Transposition of the great arteries | 90 | 21 | 38 | 59 | 36 | 26.00 | 5.00 | 31.00 | 84 | 48 |
| 74 | Corrected TGA | 90 | 23 | 36 | 59 | 39 | 27.00 | 4.00 | 31.00 | 87 | 48 |
| 75 | DORV and atrial isomerism | 90 | 8 | 51 | 59 | 14 | 9.00 | 22.00 | 31.00 | 29 | 15 |
| 76 | Total anomalous pulmonary venous connection–cor triatriatum | 90 | 11 | 48 | 59 | 19 | 14.00 | 17.00 | 31.00 | 45 | 27 |
| 77 | Antireflux operation in the setting of gastroesophageal reflux disease | 70 | 23 | 19 | 42 | 56 | 18.00 | 10.00 | 28.00 | 64 | 10 |
Q, Question; FFEOR, pretest correct answers; PRENOOR, prestest incorrect answers; PPETOTAL, pretest total answers; FFE%, pretest percent correct; POSTOOR, posttest correct answers; POSTINOOR, posttest incorrect answers; POSTTOTAL, posttest total answers; POST%, posttest percent correct; DFF, percentage difference between pretest and posttest; SVC, superior vena cava; CV, cardiovascular; VSD, ventricular septal defect; TGA, transposition of the great arteries; DORV, double outlet right ventricle.